NCT02803931View on ClinicalTrials.gov

Assessing the Efficacy of CardiOGoniometry (CGM) to Localise the Culprit Vessel in Mixed Vessel Disease Non-ST elevatIon Myocardial infarcTION (NSTEMI)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 17, 2015

Primary Completion Date

September 6, 2016

Study Completion Date

September 6, 2016

Conditions

Acute Coronary Syndrome

Interventions

DEVICE

Cardiogoniometry

Cardiogoniometry cardiologic explorer, Enverdis GmbH medical solutions, Germany

DEVICE

12-lead ECG

Trial Locations (1)

HU16 5JQ

Castle Hill Hospital, Hull

All Listed Sponsors

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT02803931 - Assessing the Efficacy of CardiOGoniometry (CGM) to Localise the Culprit Vessel in Mixed Vessel Disease Non-ST elevatIon Myocardial infarcTION (NSTEMI) | Biotech Hunter | Biotech Hunter